stockportfolio.pro
Harmony Biosciences Holdings, Inc. Net Income 2019–2025
Harmony Biosciences Holdings, Inc. (HRMY) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $158.69M | 18.3% | +9.1% |
| FY 2024 | $145.49M | 20.4% | +12.9% |
| FY 2023 | $128.85M | 22.1% | -29.0% |
| FY 2022 | $181.47M | 41.4% | +424.5% |
| FY 2021 | $34.60M | 11.3% | +193.6% |
| FY 2020 | $-36.94M | -23.1% | +75.7% |
| FY 2019 | $-151.98M | -2535.1% | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s net income?
Harmony Biosciences Holdings, Inc. (HRMY) reported net income of $158.69M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.